期刊文献+

差异表达基因Hepsin在前列腺癌中的表达及其意义 被引量:1

Expression and Significance of Differential Expression Gene Hepsin in the Prostate Cancer
下载PDF
导出
摘要 目的探讨cDNA芯片筛选出的前列腺癌(PC)差异表达基因Hepsin在PC中的表达及其意义。方法应用RT-PCR检测Hepsin在正常前列腺组织、PC组织及PC细胞系中的表达,并进行半定量分析,同时采用免疫印迹法检测Hepsin的表达,采用免疫组织化学染色法检测40例PC标本、15例前列腺增生(BPH)标本和6例正常前列腺标本的Hepsin表达水平。结果在mRNA水平,Hepsin在PC中的表达水平高于正常前列腺组织(P=0.026),但在PC细胞系中的表达并不增高。在蛋白表达水平,正常前列腺组织未表达Hepsin,而PC及PC细胞系均表达Hepsin。PC和BPH标本免疫组化检测均为阳性,但两者间有非常高度显著性差异(P=0.000),而正常前列腺标本为阴性。结论Hepsin在PC中的表达增高,有可能作为早期诊断的标志以及基因治疗的靶基因。 Objective To evaluate the expression and significance of differential expression gene Hepsin in the prostate cancer (PC) screened by the cDNA microarray technique. Methods The techniques of semiquantitative RT-PCR and Western blotting were used to detect the mRNA and protein expression of Hepsin. Specimens of 40 cases of PC, 15 benign prostatic hyperplasia (BPH) and 6 normal prostate tissues were examined by the immunohistochemical stain. Results Hepsin was more expressed in PC tissue than normal prostate tissue (P =0. 026) and was confirmed by Western blot analysis. Immunohistochemical test confirmed this and demonstrated that Hepsin did not expressed in normal prostate but expressed in PC and BPH and there was a significant difference in Hepsin expression level between PC and BPH tissues (P =0. 000). Conclusion Hepsin high expressed in PC may be a new molecular marker in early diagnosis of PC and a new target for gene therapy of PC.
出处 《中国康复理论与实践》 CSCD 2006年第12期1060-1062,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 前列腺癌 基因表达 Hepsin基因 prostate cancer gene expression Hepsin gene
  • 相关文献

参考文献16

  • 1周利群 黄啸 杨学贞.基因微矩阵芯片在前列腺癌相关基因筛选中的应用研究[J].中华泌尿外科杂志,2000,23:72-75.
  • 2Oberst MD,Johnson MD,Dickson RB,et al.Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer:Correlation with clinical outcome and tumor clinicopathological parameters[J].Clin Cancer Res,2002,8:1101-1107.
  • 3Oberst M,Anders J,Xie B,et al.Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo[J].Am J Pathol,2001,158:1301-1311.
  • 4Tanimoto H,Underwood LJ,Wang Y,et al.Ovarian tumor cells express a transmembrane serine protease:A potential candidate for early diagnosis and therapeutic intervention[J].Tumour Biol,2001,22:104-114.
  • 5Yamaguchi N,Okui A,Yamada T,et al.Spinesin/TMPRSS5,a novel transmembrane serine protease,cloned from human spinal cord[J].J Biol Chem,2002,277:6806-6812.
  • 6Lang JC,Schuller DE.Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck[J].Br J Cancer,2001,84:237-243.
  • 7Underwood LJ,Shigemasa K,Tanimoto H,et al.Ovarian tumor cells express a novel multi-domain cell surface serine protease[J].Biochem Biophys Acta,2000,1502:337-350.
  • 8Luo J,Duggan DJ,Chen Y,et al.Human prostate cancer and benign prostatic hyperplasia:molecular dissection by gene expression profiling[J].Cancer Res,2001,61:4683-4688.
  • 9Magee JA,Araki T,Patil S,et al.Expression profiling reveals Hepsin overexpression in prostate cancer[J].Cancer Res,2001,61(15):5692-5696.
  • 10Welsh JB,Sapinoso LM,Su AI,et al.Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer[J].Cancer Res,2001,61:5974-5978.

共引文献1

同被引文献19

  • 1赵伟光,张建林,吴建国,朱应,李雁,朱忠超,刘志苏.HBx蛋白与Hepsin共表达可促进HBV复制[J].中国病毒学,2004,19(4):345-348. 被引量:1
  • 2曹泽毅主编.中华妇产科学[M].第2版,北京:人民卫生出版社,2008:398-419.
  • 3Zou Z, Anisowicz A, Hendrix M J, et al. Maspin, a serpin with tumor -suppressing activity in human mammary epithelial cells [ J ]. Science, 1994,263:526 - 529.
  • 4Livat KJ , Schmittgen TD. Analysis of relative gene expression data using real- time quantitative PCR and the 2-~ct Method [J].Methods ,2001,25 (4) :402 - 428.
  • 5Tanimoto H Y, Yan Y, Clark J, et al. Hepsin, a cell surface serineprotease identified in epatoma cells, is overexpressed in ovarian cancer[ J]. Cancer Res, 1997, 57 (14) : 2884 - 2887.
  • 6Magee J A, Araki T, Patil S, et al. Expression profiling reveals hepsin overexpression in prostate cancer[ J]. Canncer Res, 2001, 61 ( 15 ) : 5692 - 5696.
  • 7Hooper J D, Clements J A, Quigley J P, et al. Type II transmembrane serine proteases insights into an emerging class of cell surface proteolytie enzymes[ J]. J Biol Chem, 2001,276(2) : 857 - 860.
  • 8Kirchhofer D, Peek M, Lipari M T, et al. Hepsin activates pro - hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor - 1 B ( HA I - 1B) and HA I - 2 [J].FEBS Lett,2005, 579(9) :1945 -1950.
  • 9Corso S, Comoglio PM, Giordano S. Cancer therapy : can challenge be MET [ J ]. Trends Med, 2005,11 ( 6 ) :284 - 292.
  • 10Herter S, PiperD E, Aaron W, et al. Hepatocyte growth factor is a p referred in vitro substrate for human hepsin, a membrane-an- chored serine protease implicated in prostate and ovarian cancers [J]. Biochem J, 2005, 390 : 125-136.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部